Real-world treatment patterns and outcomes in Indian patients with HR+/HER2- advanced breast cancer treated with palbociclib [0.03%]
帕博西尼治疗HR+/HER2-晚期乳腺癌的现实世界中的治疗模式和疗效：印度患者的资料
Senthil Rajappa,Ajay Bapna,Devavrat Arya et al.
Senthil Rajappa et al.
Background: Palbociclib, a CDK4/6 inhibitor, was approved by FDA in 2015 for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC). It was...
Observational Study
Journal of cancer research and therapeutics. 2026 Jan 1;22(1):97-103. DOI:10.4103/jcrt.jcrt_1552_25 2026
Comparison of the effects of intrathecal hyperbaric bupivacaine, levobupivacaine, and ropivacaine during interventional brachytherapy: A double-blind, randomized crossover study [0.03%]
腰麻布比卡因、莱沃布比卡因和罗哌卡因在盆腔近距离放射治疗期间的效果比较：双盲随机交叉试验
Prateek Maurya,Surjyendu Ghosh,Nishkarsh Gupta et al.
Prateek Maurya et al.
Background: The choice of intrathecal local anesthetic influences discharge readiness and brachytherapy success. Evidence comparing hyperbaric bupivacaine, levobupivacaine, and ropivacaine is limited. ...
Randomized Controlled Trial
Journal of cancer research and therapeutics. 2026 Jan 1;22(1):90-96. DOI:10.4103/jcrt.jcrt_2101_25 2026
Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study [0.03%]
子宫颈癌腔内放射治疗时盆骨骨髓接受剂量之测量研究报告
Ajeet Kumar Gandhi,Madhup Rastogi,Vikas Sharma et al.
Ajeet Kumar Gandhi et al.
Purpose: Current dose-volume constraints for pelvic bone marrow (PBM) sparing in radiotherapy for locally advanced cervical carcinoma (LACC) typically do not account for the dose contribution from intracavitary brachyther...
Identifying high-risk groups for recurrence in endometrial cancer: The role of ESMO-ESGO-ESTRO risk classification [0.03%]
子宫内膜癌复发高危人群的识别：欧洲医学肿瘤学会－欧洲妇科肿瘤学会－欧洲放射治疗与临床肿瘤学会风险分层的作用
Ömer F Elçiçek,Özge Yalici,Kubilay Karaboyun et al.
Ömer F Elçiçek et al.
Objective: This study aimed to identify prognostic factors associated with recurrence in patients with stages I-III endometrial cancer who underwent surgical treatment. ...
Predictive value of lymph node ratio on survival outcomes in esophageal squamous cell carcinoma: A tertiary cancer centre experience [0.03%]
淋巴结比率对食管鳞癌生存预后的影响：一家三级癌症中心的经验
Naveen Kumar,Chinmay Bagla,Sandeep Bhoriwal et al.
Naveen Kumar et al.
Introduction: Squamous cell carcinoma (SCC) is the most common type of esophageal cancer in the developing world. The nodal staging for it is based on the number of positive nodes at present. Lymph node ratio (LN ratio) h...
Regulatory effects of miRNA in epithelial ovarian cancer patients: A case-control study from Eastern India [0.03%]
微小核糖核酸在上皮性卵巢癌患者中的作用：一项来自印度东部的病例对照研究
Suchitra Kumari,Ramadaas Balamurugan,Saroj K D Majumdar et al.
Suchitra Kumari et al.
Introduction: Current biomarkers of epithelial ovarian cancer (EOC) lack the required sensitivity and specificity for early detection. MicroRNAs (miRNAs) are implicated in cancer progression, and their serum expression co...
Estimation of set-up errors and planning target volume margin in craniospinal irradiation: A prospective study [0.03%]
立体定向放射治疗中定位误差及计划靶区Margins的估计：一项前瞻性研究
Sureka Dhayalan,Renu Madan,Arun S Oinam et al.
Sureka Dhayalan et al.
Background: Cranio-spinal irradiation (CSI) planning is complex due to large target volume and numerous organs at risk (OARs). In the index study, we assessed set-up errors and daily shifts during CSI using cone-beam comp...
Epstein-Barr virus latent membrane protein-1 expression in nasopharyngeal carcinoma with clinical correlation. A study in North East India [0.03%]
与临床相关性 EB病毒潜伏膜蛋白-1在鼻咽癌中的表达研究(印度东北部的研究)
Nito Yepthomi,Mejungsangla Longkumer,Khrutsozo Kikhi et al.
Nito Yepthomi et al.
Background: Nasopharyngeal carcinoma (NPC) is a malignant mucosal epithelial neoplasm covering the nasopharynx with varied geographical distribution. A number of etiological factors have been associated with the developme...
Patterns and outcomes of radiotherapy in octogenarian and nonagenarian patients: Experience from a Tertiary Care Center in North India [0.03%]
印度北部三级医疗中心八九十岁老年患者的放疗模式和预后经验
Vandana Thakur,Pratibha Prashar,Hardik Sharma et al.
Vandana Thakur et al.
Background: The elderly population (≥80 years) represents a growing demographic in oncology, yet remains underrepresented in clinical trials. With advancements in radiotherapy (RT) techniques, its role in managing cancer...
Aging and the global cancer burden: A population-based cohort study and predictive modelling analysis using the global cancer database [0.03%]
人口统计为基础的队列研究和使用全球癌症数据库预测模型分析癌症负担与老龄化的关系
Manas Pustake,Mohammad Arfat Ganiyani,Swarada Joshi et al.
Manas Pustake et al.
Background: As the global population is aging, the impact of cancer among the elderly have become critical areas of study. This demographic shift is expected to continue, necessitating detailed analysis for effective plan...